NEDBANK GROUP LIMITED - Unaudited Interim Financial Results for the 6 Months ended 30 June 2026 and Cash Dividend Declaration
What this filing means
A mixed result with genuine underlying positives obscured by legitimate balance-sheet concerns. Preliminary headline earnings were essentially flat at +0.1%, but excluding the disposed ETI associate income, underlying HE growth was reported at 12% on revenue up 6% to R38.2bn — real operational momentum beneath the headline. The offsetting concern is a 14 bps deterioration in the credit loss ratio to 95 bps and a 50 bps decline in the CET1 ratio, raising asset-quality and capital questions. The interim dividend rose 2% to 1,052c/share, confirming income continuity but not enough to offset the mixed quality picture.
Nedbank made more revenue and kept costs well-controlled, which is genuinely positive. However, it had to set aside significantly more money for bad loans than a year ago, and it holds less capital relative to its risk exposures than it did in H1 2025. The flat headline earnings number hides a better underlying story — but the deterioration in credit and capital is real, not noise, and the per-share earnings growth was partly achieved by buying back shares rather than purely from the business earning more. The dividend rose modestly, which shareholders will welcome, but the quality of the earnings is the debate.
Bull case
- Excluding the disposed ETI associate, underlying HE growth was 12% on revenue up 6% to R38.2bn, evidencing real operational momentum beneath the flat headline print.
- Cost-to-income ratio improved to 56.2% from 56.9%, with expenses contained at +3% against revenue +6% — a positive jaws outcome.
- ROE of 15.0% remained above the group's 14.0% cost of equity, supporting a +2% interim dividend to 1,052c per share declared from income reserves.
- NCBA offer closed with 79.9% acceptance, achieving the targeted 66% shareholding, with remaining regulatory approvals expected end-Q3/early-Q4 2026 — a clear diversification catalyst.
- Diluted HEPS of 1,803c was up 2%, ahead of HE growth thanks to well-timed 2025 share buybacks — accretive capital management.
Bear case
- Credit loss ratio worsened to 95 bps from 81 bps, a 14 bps jump in impairments that signals rising asset-quality risk.
- CET1 ratio fell to 12.6% from 13.1%, narrowing capital headroom just as the NCBA acquisition is still awaiting final regulatory approval.
- Diluted HEPS rose 2% while headline earnings grew only 0.1%, revealing that per-share growth was buyback-driven rather than operational.
- Management's forward guidance and 2028 ROE targets have not been reviewed or reported on by the group's joint auditors.
- The SENS release omits pro forma CET1, funding plan, and earnings accretion/dilution for NCBA, leaving integration economics unquantified ahead of Q3/Q4 approvals.
AI-generated summary by SENS-AI, based on the original JSE SENS filing.
SENS-AI conclusion
A genuinely two-tier result: the operational core — 6% revenue growth, 12% underlying HE growth ex-ETI, a positive jaws outcome with expenses up only 3% — is substantive. But the deterioration in credit quality (95 bps vs 81 bps) and the 50 bps decline in CET1 are not cosmetic. Per-share growth of 2% is flattering relative to flat headline earnings because of prior buybacks, not because the business earned more on every rand of assets. The interim dividend rising to 1,052c is a modest positive for income-focused holders. At this rating the read is balanced: neither a clean result to own, nor one that warrants selling on the numbers. So what: the credit trend and the NCBA regulatory path are the two variables that will most shape whether the underlying momentum is durable. Missing evidence: No prior trading statement range to assess surprise vs expectations; Net interest income and non-interest revenue absolute figures not disclosed in short-form; NCBA acquisition purchase price and funding method not quantified; Full income cascade (NII, NIR, impairments, expenses) unavailable in short-form; H2 HE growth guidance is qualitative ('improvement') without numeric range; No cash flow statement or loan/deposit growth metrics disclosed
The H2 results and NCBA final regulatory clearance are where the market will test whether the revenue growth sustains through a deteriorating credit cycle.
Evidence from the filing
Excluding the disposed ETI associate, underlying HE growth was 12% on revenue up 6% to R38.2bn, evidencing real operational momentum beneath the flat headline print.
“HE benefited from improving net interest income growth, strong non-interest revenue growth and very disciplined expense management, offset by a higher impairment charge and no further recognition of associate income from Ecobank Transnational Incorporated (ETI) following the disposal of our investment in 2025”
Cost-to-income ratio improved to 56.2% from 56.9%, with expenses contained at +3% against revenue +6% — a positive jaws outcome.
“Cost-to-income ratio of 56.2% (June 2025: 56.9%)”
ROE of 15.0% remained above the group's 14.0% cost of equity, supporting a +2% interim dividend to 1,052c per share declared from income reserves.
“Return on equity (ROE) of 15.0% (H1 2025: 15.2%) remained above the group's cost of equity of 14.0%”
NCBA offer closed with 79.9% acceptance, achieving the targeted 66% shareholding, with remaining regulatory approvals expected end-Q3/early-Q4 2026 — a clear diversification catalyst.
“The offer closed on 10 July 2026 and was accepted by shareholders representing 79.9% of NCBA shares in issue, enabling us to achieve our targeted 66% shareholding. Key regulatory approvals have been obtained, with the remaining approvals expected towards the end of Q3 or early in Q4 of 2026”
Diluted HEPS of 1,803c was up 2%, ahead of HE growth thanks to well-timed 2025 share buybacks — accretive capital management.
“Diluted headline earnings per share of 1 803 cents, up by 2% (June 2025: 1 762 cents)”
Credit loss ratio worsened to 95 bps from 81 bps, a 14 bps jump in impairments that signals rising asset-quality risk.
“Credit loss ratio of 95 bps (June 2025: 81 bps)”
CET1 ratio fell to 12.6% from 13.1%, narrowing capital headroom just as the NCBA acquisition is still awaiting final regulatory approval.
“Common equity tier 1 ratio of 12.6% (June 2025: 13.1%)”
Management's forward guidance and 2028 ROE targets have not been reviewed or reported on by the group's joint auditors.
“Our guidance and targets are not profit forecasts and the group's joint auditors have not reviewed or reported on them”
More on Nedbank Group Limited
Related filings
More from NED
- NEDBANK GROUP LIMITED - Nedbank Group and Nedbank Limited Changes to the Boards of Directors, Board Committees and Classification of Directors
- NEDBANK GROUP LIMITED - The Central Bank of Kenya approval received for Nedbank Groups Offer to Acquire C.66% of NCBA Group Plc
- NEDBANK GROUP LIMITED - Pillar 3 Risk and Capital Management Report for the 6 Months ended 30 June 2026
- NEDBANK GROUP LIMITED - Resignation of Director and Changes to Board Committees
- NEDBANK GROUP LIMITED - Nedbank Group Executive Leadership Change Retirement of Mfundo Nkuhlu
Other Results
- REMREMGRO LIMITED - Summary of audited results for the year ended 30 June 2026 and cash dividend declarations
- CHPCHOPPIES ENTERPRISES LIMITED - Audited Group financial results for the year ended 30 June 2026
- SACSA CORPORATE REAL ESTATE LIMITED - Unaudited condensed consolidated interim financial results for the six months ended 30 June 2026 and cash dividend declaration
- BANK WINDHOEK LIMITED - Publication of annual financial statements for the year ended 30 June 2026
- MTMMOMENTUM GROUP LIMITED - Annual results for the year ended 30 June 2026, dividend declaration and availability of annual financial statements